Human neural stem cells alleviate 'chemo brain'

Study reveals how they restore cognitive functions impaired by chemotherapy.

Why do some targeted cancer drugs lose effectiveness?

Protein may be to blame; study suggests combination therapies could overcome drug resistance.

FDA approves new breast cancer drug

UCLA research played key role in development of Ibrance, targeting estrogen-receptor–positive breast cancer.

Cancer cell mapping initiative launches

Researchers from UC San Diego and UC San Francisco join forces to determine how all of the components of a cancer cell interact.
Brittany Maynard

Brittany Maynard plans to end her life

In the face of a terminal diagnosis, the UC Berkeley grad has taken control of her life — and death.

Genetic variant protects some Latina women from breast cancer

Originating from indigenous Americans, variant reduces risk by 40 to 80 percent.
Ted Ognibene, Mike Malfatti and biological AMS instrument

Lab, UC Davis partner to personalize cancer medications

Researchers are using biological accelerator mass spectrometry to see how cancer patients respond to specific chemotherapy.
Melanoma drug Keytruda in action

FDA approves new melanoma drug

Drug that turns on the immune system to fight deadly cancers is a ‘game changer,’ says study’s principal investigator.

Survey finds e-cigarette online market on fire

Researchers find that there are 466 brands online and 10 new brands introduced every month, making regulating the market increasingly complex.

Longer telomeres linked to brain cancer risk

Gene variants may promote overall health while increasing risk of gliomas.